You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
28 August 2026 - Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company based in Sydney, Australia, announced on Thursday new data showing that its lead asset, paxalisib, achieved a 100% clinical benefit rate in six ev...
28 August 2026 - Clinical-stage biopharmaceutical company Duality Biotherapeutics Inc (DualityBio) (HKEX: 09606) announced on Friday that it has entered into a collaboration and licence agreement with biotechnology company Genentech, a member of the ...
27 August 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) announced on Thursday that it has applied to the European Medicines Agency for approval of subcutaneous induction dosing of SKYRIZI (risankizumab) for adults with moderately to severel...
27 August 2026 - Biopharmaceutical companies AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Amgen Inc (NASDAQ:AMGN) on Thursday reported positive results from the Phase III CROSSING trial showing that Tezspire (tezepelumab) delivered statisticall...
27 August 2026 - Swedish clinical-stage biotech company Oxcia AB, which develops therapies targeting oxidative stress and DNA damage response pathways, announced on Thursday that the European Medicines Agency has made the decision to grant Orphan Dru...
27 August 2026 - Clinical-stage biotechnology company Graviton BioScience Corporation announced on Wednesday the publication of peer-reviewed data from a multicentre Phase Ib/II multi-dose, open-label clinical trial evaluating the safety, tolerabilit...
27 August 2026 - Cizzle Bio Inc, a biotechnology company advancing biomarker blood tests for early cancer detection, announced on Wednesday its participation in the 18th Annual Next Generation Dx Summit in Washington, D.C.On Monday, Dr. Lary A. Robin...